ACW | Small Caps

Actinogen Medical ASX ACW cognitive improvement Xanamem XanaHES Alzheimer’s disease neurological

Actinogen Medical announces ‘breakthrough’ study results for Alzheimer’s drug Xanamem

October 1, 2019

Actinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safety study first initiated last year. The results reaffirm the foundational hypothesis...

Read more

Actinogen Medical ASX ACW Phase 2 Alzheimer's disease trial results fail dementia

Actinogen Medical phase two Alzheimer’s clinical trial disappoints

May 7, 2019

Biotech company Actinogen Medical (ASX: ACW) has reported a mixed bag of results including some disappointing outcomes from its XanADu phase two clinical trial...

Read more

Actinogen Medical ASX ACW US biotech investor Alzheimer’s XanADu study

Actinogen Medical attracts US biotech investor as Alzheimer’s XanADu study remains on track

May 23, 2018

Actinogen Medical (ASX: ACW) has received a double-shot of positive news earlier today after the biotech company received the all-clear from the Data Safety and Monitoring...

Read more

Actinogen Medical ASX ACW XanADu treat Alzheimer’s disease

Actinogen moves towards XanADu starting line to treat Alzheimer’s disease

March 21, 2018

Biotech company Actinogen Medical (ASX: ACW) has confirmed that it has obtained half of the required patients in order to conduct its landmark Phase...

Read more

RECENT POSTS

Windlab Federation Asset Management Holdings ASX WND

Windlab receives $68m takeover offer from Federation Asset Management

January 20, 2020

Rox Resources Venus Metals Youanmi ASX RXL VMC gold project results

Youanmi delivers more high-grade gold results for Rox Resources and Venus Metals

January 20, 2020

Ganfeng Lithium International Galan ASX GLN register

Galan Lithium welcomes Ganfeng as a shareholder as lithium brine results continue to impress

January 20, 2020

G Medical Innovations ASX GMV Prizma China Taiwan FDA approval

G Medical picks up Taiwan market approval for Prizma device

January 20, 2020

STOCK SUMMARY

INVESTOR TOOLS

HOT TOPICS

F45 Training US IPO Mark Wahlberg listing Australia

Australian fitness chain F45 Training files for US listing

January 20, 2020

Chinese growth ASX record high 2020 trade war United States Australia share market

Weekly review: Chinese growth pushes ASX to new record high

January 18, 2020

Cash payments $10000 law Australia

Law to restrict cash payments to $10,000 has many critics

January 16, 2020

TRENDING POSTS

Cash payments $10000 law Australia

Law to restrict cash payments to $10,000 has many critics

Chinese growth ASX record high 2020 trade war United States Australia share market

Weekly review: Chinese growth pushes ASX to new record high

Lithium miners rally ASX Chinese electric vehicle subsidy EV

Lithium miners rally on Chinese electric vehicle subsidy news

Alaska North Slope oil discovery drilling 2020 Nanushuk

ConocoPhillips, Oil Search, 88 Energy and XCD Energy highly leveraged to winter exploration on Alaska’s North Slope

Cobre ASX IPO CBE base metals mining resources

Cobre to list on ASX after heavily oversubscribed IPO

Cannabis stocks ASX medicinal marijuana pot

Cannabis stocks on the ASX: The Ultimate Guide

Black Cat Syndicate ASX BC8 Bulong Gold Project RC diamond drilling Myhree

Black Cat unearths ‘second-best’ gold assay to-date at Myhree extension

Lithium stocks ASX

Lithium stocks on the ASX: The Ultimate Guide

Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.